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Introductory paragraph (150 words.)
Expansion of the brain is one of the defining characteristics of modern humans.
Seckel syndrome (MIM210600), a disorder of markedly reduced brain and body size1,
is associated with defective ATR-dependant DNA damage signalling2. Previously,
only a single hypomorphic mutation of ATR has been identified in this genetically
heterogeneous condition3. We now report that mutations in pericentrin (PCNT) also
cause Seckel syndrome, resulting in its loss from the centrosome, where it has key
functions anchoring both structural and regulatory proteins4,5. Furthermore, we find
that PCNT-Seckel patient cells have defects in ATR-dependent checkpoint signalling,
providing the first evidence linking a structural centrosomal protein with DNA
damage signalling. These findings also suggest that other known microcephaly genes
implicated in either DNA repair responses6 or centrosomal function7,8, may act in
common developmental pathways determining human brain and body size.
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Seckel syndrome is an autosomal recessive disorder of intra-uterine growth
retardation, severe proportionate short stature and marked microcephaly1,9. The
ataxia-telancgiectasia and Rad3-related (ATR) gene is mutated in Seckel syndrome
(ATR-Seckel)3, and encodes an phosphotidylinositol-3-kinase-like kinase which has
distinct, but overlapping functions with ATM in co-ordinating the response to DNA
damage10. ATR is activated by single stranded DNA whilst ATM responds to DNA
double strand breaks. MCPH1, another gene whose mutations cause severe (primary)
microcephaly, also acts in the ATR damage response pathway6. Furthermore, other,
non-ATR Seckel patient cell lines also exhibit ATR-pathway dysfunction2, suggesting
that mutation of further genes encoding proteins involved in this DNA damage
response cascade may cause this disorder.
To identify such components, we performed a SNP-microarray genome-wide
homozygosity scan on two consanguineous families from the Middle-East with a
clinical diagnosis of Seckel syndrome (Supplementary Fig. 1 and 2) and cellular
evidence of defective ATR signalling. Multipoint linkage analysis identified a novel
locus, Sckl4, with a maximum LOD score of 4.03 at 70.9cM on chromosome 21q22.3
between rs1598206 and rs2330591 (Fig. 1 and Supplementary Fig. 2). 55 Refseq
annotated genes lay within this interval, including pericentrin (PCNT), which encodes
a centrosomal protein. As several centrosomal genes, CenpJ, ASPM and CDK5RAP2,
cause the related condition, primary microcephaly7,8, we postulated that PCNT might
be the causative gene and therefore sequenced its 47 coding exons in affected
individuals from both families.
We identified a homozygous nonsense mutation in exon 4 of family 1 (E220X). A
homozygous single base-pair deletion in exon 12 in family 2 (S629fs, Fig. 1c,d)
produces a frameshift, predicted to result in premature protein truncation after an
additional 65 amino acids. Both mutations segregated with the disease in each family,
with all parents being heterozygous for the respective mutations. From screening of
additional cases we identified a further patient of Moroccan ancestry with a
homozygous single base-pair insertion in exon 18, resulting in a frameshift at codon
1190 (C1190fs). Neither this, nor the other two mutations were present in over 200
control alleles screened. Taken together, these mutations disrupt all described
3mammalian protein isoforms of PCNT11,12. Therefore we surmised that homozygous
loss of function mutations in PCNT cause Seckel syndrome.
Pericentrin (also known as kendrin) is a huge 360kDa coiled-coil protein with a C-
terminal PACT domain that targets it to the centrosome (Fig. 1d). Two protein
isoforms have been described in humans11, the full length protein, pericentrin B, and a
C-terminally truncated isoform, pericentrin A. Pericentrin localises to the
pericentriolar material (PCM), where it interacts with several structural centrosomal
proteins, including γ-tubulin and PCM1
13,14 and is important for microtubular
nucleation and spindle organisation15,16 Anti-pericentrin antibodies disrupt mitosis,
suggesting it is essential for mitotic progression15. However, its Drosophila homolog,
D-PLP, though required for timely recruitment of PCM components, is apparently
dispensible for cell division17. Furthermore, as well as its structural roles, pericentrin
acts as a scaffold to recruit signalling proteins, such as Protein Kinase A (PKA) and
Protein Kinase CβII, to the centrosome4,18.
As all mutations identified were homozygous and significantly truncated the protein,
this would suggest that they are functionally ‘null’ alleles. To test this prediction, we
examined pericentrin localisation in patient lymphoblastoid cell lines (LCLs).
Centrosomal pericentrin staining was lost in three independent LCLs, in contrast to
control cell lines (Fig. 2a and Supplementary Fig. 3), both in interphase and mitosis.
As different isoforms of pericentrin have been described, we also examined protein
expression by immunoblotting (Fig. 2b and Supplementary Fig. 3). Two bands were
detected in controls (Wild-type (WT), and heterozygous relatives, PCNTE220X/+,
PCNTS629fs/+), representing two isoforms of pericentrin, which were not present in
mutant LCLs. A smaller ~190kD band was present in PCNTE220X lymphoblastoid
cells, (probably representing an aberrant truncated PCNT protein product), while no
significant PCNT protein was apparent in the other two mutant cell lines, therefore
supporting the molecular genetic findings that protein function is significantly, if not
completely, disrupted.
We next examined other components of the centrosome, to establish if they were
affected by the absence of pericentrin. ASPM, PCM-1, ninein and centrin were all
localised normally (Fig 2a and Supplementary Fig. 4).  However, during mitosis, γ-
4tubulin was reduced or absent (Fig 2c, d), consistent with previous RNAi
experiments5.
Other patients with Seckel syndrome are defective in the ATR DNA damage response
pathway2. We therefore assessed PCNT-Seckel patient cell lines to see if loss of this
key centrosomal protein is associated with the defects in ATR signalling previously
found to be associated with this disorder2,3. Indeed, PCNT-Seckel (PCNTC1190fs,
PCNTE220X and PCNTS629fs) LCLs exhibited defective UV-induced G2-M checkpoint
arrest, similar to that seen in ATR-Seckel patients (Fig. 3a), in contrast to cell lines
established from heterozygote relatives (PCNTE220X/+, PCNTS629fs/+) and an unrelated
wild type control. This suggested that mutations in PCNT impact on ATR-dependent
cell cycle checkpoint activation. Similarly, PCNT-Seckel LCLs also exhibited
elevated nuclear fragmentation following replication fork stalling (Fig. 3b) and
supernumerary mitotic centrosomes (Fig 3c), two further cellular phenotypes caused
by impaired ATR-signalling2.
Since, these findings suggested a direct role for PCNT in ATR-dependent DNA
damage response signalling, we examined further steps in this signalling cascade in
PCNT-Seckel cells. We found that ATR-dependent H2AX formation was normal in
Seckel-PCNT LCLs, similar to controls (Fig 3d). This was distinct from ATR-Seckel
LCLs and suggested that ATR is able to phosphorylate a key substrate in PCNT-
Seckel syndrome. Thus, Pericentrin functions downstream of ATR kinase activation
in this pathway.
We next examined hydroxyurea-induced 53BP1 foci formation in PCNT-Seckel cell
lines. Strikingly, both PCNT-Seckel and ATR-Seckel LCLs failed to form such foci in
contrast to control cell lines (Fig 3e). This phenotype is dependent on both ATR and
Chk1 kinases, indicating that PCNT has a downstream role in ATR-pathway function
To determine whether PCNT mutations affect other DNA damage responses, we
assessed the G2-M checkpoint response to DNA double strand breaks induced by
ionising radiation. This response is specifically dependent on ATM and not ATR
signalling. PCNT-Seckel LCLs arrested as efficiently as control LCLs under these
conditions. ATR-Seckel, unlike ATM mutant LCLs also had a normal response,
5confirming the ATR-independence of this assay (Fig 3f). Therefore, we concluded
that mutations in PCNT have specific effects on the downstream stage of the ATR-
pathway including G2-M checkpoint activation.
PCNT is a key structural centrosomal protein nucleating microtubular assembly
during mitosis15,16. It was thus surprising to identify homozygous truncating
mutations that appear to cause absence of known forms of the PCNT protein from
centrosomes. So remarkably, PCNT would seem to be dispensable for most aspects of
human development. Pericentrin mutations do however dramatically reduce both
body and brain size by ~ 8 standard deviations below the norm. Other centrosomal
genes (ASPM, CDK5RAP2, CENPJ) have been implicated in determining human
brain size, being mutated in primary microcephaly. They are presumed to act through
effects on neurogenic mitosis, perhaps modulating symmetric/asymmetric cell
division7,8,19. Given PCNT’s role in mitotic spindle assembly15,16 and in co-ordinating
mitotic entry5, perturbation of mitosis may similarly result in globally reduced cell
number, so additionally causing reduced body size. Alternatively as reduced body
size is also present in both ATR-Seckel and MCPH1 primary microcephaly, which
correlates with impaired ATR-signalling, reduced cell survival could provide an
alternative explanation for reduced brain and body size.
ASPM and MCPH1 primary microcephaly genes have undergone significant adaptive
evolution in primates, suggesting that functional alterations in the proteins they
encode may have contributed to the evolution of human brain size20.
Morphologically, Seckel syndrome also has evolutionary parallels. Homo
Floresiensis, the recently described Indonesian hominid, has similarly marked
reduced brain and body size (cranial volume -6.1 s.d, height -9.5 s.d, relative to
modern humans)21. Consequently, changes in this or similar genes could underlie the
anatomical differences seen in this hominid22.
Through study of a human disease phenotype, we have for the first time implicated a
structural protein of the centrosome in the ATR-dependent DNA damage response.
Centrosomes have a central role in regulating cell cycle progression23 and pericentrin
has an established role in recruiting regulatory proteins to the centrosome4,18.
6Therefore a role in checkpoint signalling would be consistent with its known
functions.
Components of the ATR-pathway have been observed to localise to the centrosome24,
most notably Chk125,26. Chk1 centrosomal localisation, mediated by activating
phosphorylation at Serine317 and 345 residues27, is enhanced by DNA damage. At the
centrosome, Chk1 is thought to mediate G2/M arrest through inhibiting activation of
Cyclin B-Cdk1 by Cdc25 26. Intriguingly, fusion of Chk1 with a PACT domain
prevents G2/M mitotic progression26, suggesting that endogenous pericentrin, one of
only two PACT domain containing proteins, could provide the means of Chk1
localisation to mediate G2/M checkpoint arrest (model, Fig. 4).
The identification of Pericentrin mutations in Seckel syndrome also provides an
interesting convergence between microcephaly genes implicated in ATR signalling
(MCPH1, ATR) and those involved in centrosomal function (ASPM, CDK5RAP2,
CENPJ). This suggests that further biochemical and developmental investigation is
likely to be fruitful in delineating a common cellular pathway responsible for the
brain and body size phenotypes in these syndromes.
Methods
Affected individuals with Seckel syndrome
All affected individuals included in this study had a diagnosis of Seckel syndrome,
having intrauterine growth retardation, severe proportionate short stature, marked
microcephaly and developmental delay. Blood samples were obtained with informed
consent from affected children, parents and unaffected siblings. Lymphoblastoid cell
lines were established by EBV transformation and Genomic DNA extracted using
standard methods. The study was approved by the Scottish Multicentre
ResearchEthics Committee 04:MRE00/19), and University of Sussex
School of Life Sciences Research Governance Committee.
7Genotyping and linkage analysis
SNP microarray genotyping was performed by AROS Applied Biotechnology
(Denmark) using Affymetrix Human Mapping 50k Xba240 Genechips. SNP
genotypes were analysed using Alohombra28 and multipoint linkage analysis
performed with GENEHUNTER (version 2.0β) under a model of autosomal recessive
inheritance with full penetrance, using a disease allele frequency estimated at 1 in
1,000. Decode genetic map distances and Affymetrix SNP allele frequencies were
used.
Mutation detection
Primers were designed using the ExonPrimer tool in UCSC Genome Browser to
amplify coding exons of pericentrin (primer sequences listed in Supplementary
Table 1). Purified PCR amplification products were sequenced using dye-terminator
chemistry and electrophoresed on an ABI 3730 capillary sequencer (Applied
Biosystems). Mutation analysis was performed using Mutation Surveyor
(Softgenetics). Anonymised control samples were screened by sequencing.
Cell lines and cell culture
LBLs were cultured in RPMI 1640 with 15% fetal calf serum (FCS). Cells used were
Wild-type (WT; GM02188), ATR-Seckel (DK0064), Ataxia Telangiectasia-mutated
(ATM; GM03189D), all of which are described previously 3,6. PCNTE220X, (CV1559;
affected Seckel, PCNT 658G>T), PCNTE220X/+, (CV1584; unaffected brother of
CV1559), PCNTS629fs (CV1576; affected Seckel, PCNT 1887delA), PCNTS629fs/+
(CV1582; unaffected mother of CV1576) and PCNTC1190fs (12061; affected Seckel,
PCNT 3568_3569insT).
Immunofluorescence and Western Blotting
Immunostaining was performed as previously described29.Antibodies were used at the
following dilutions: pericentrin (Abcam, ab448-100) 1:1000; pericentrin (N-20)
(Santa Cruz Biotechnology) 1:100; -tubulin (Sigma) 1:1000; Centrin (A.Merdes) 1:
1000; PCM-1 (A.Merdes) 1: 1000; ASPM (Bethyl labs, IHC-00058); 1:250; Ninein
(A.Merdes) 1:100. Secondary antibodies were FITC or Texas Red conjugated
(Jackson Immunoresearch lab), 1:200. Three dimensional data sets were collected
with a DeltaVision system (Applied Precision, Issaquah,WA) based on an Olympus
8IX-70 with a Chroma Technology Sedat filter set driven by SoftWorx software under
standard conditions. All images were archived as raw (r3d) and deconvolved (d3d)
files. Images were subjected to standard deconvolution algorithm. Three dimensional
data sets were converted to Quick Projections in SoftWorx and then converted to
TIFF files and imported into Adobe Photoshop for final presentation. For the
quantification of -tubulin staining in mitosis, a defined volume containing the
centrosome was used to measure the total intensity of the signal. The same volume
was used to identify the background noise as intensity outside the cells and the non-
centrosomal gamma tubulin. The ratios of centrosome-bound and dispersed gamma
tubulin was averaged for each slide after background subtraction and the relative
intensity was calculated in comparison to the WT control slide.
Immunoblotting was performed using pericentrin (Abcam, ab448-100) antibody at
1:1000, and HRP conjugated anti-rabbit IgG secondary 1:5000 (Cell signalling 7074),
detected with ECL-Plus (Amersham).
DNA damage response assays
For ATR-dependent G2-M arrest cells were untreated (UNT) or irradiated with 5 J/m2
UV-C (UV) and immediately seeded into complete medium, incubated for 2 hrs,
before being cytospun onto poly-D-lysine coated slides and stained with DAPI as
previously described6. For the ATM-dependent G2-M arrest cells were either
untreated (UNT) or irradiated with 2Gy ionising radiation (IR) and processed as
above. For H2AX formation and 53BP1 foci formation, cells were either untreated
(UNT) or treated with 5 mM hydroxyurea (HU) for 2 hrs and processed for
immunofluoresence (IF) staining as previously described2. Cells were also pulse
labelled (15 mins) with 50M BrdU to allow quantification of S-phase using anti-
BrdU by IF. Supernumerary mitotic centrosomes were determined following
treatment with 1.5M nocodazole for 24 hrs as previously described6. Anti-H2AX
was obtained from Upstate Technology (Hampshire, UK), anti-53BP1 (BL181) from
Universal Biologicals (Cambridge, UK), anti-BrdU from Autogen Bioclear
(Wiltshire, UK) and anti-tubulin from Sigma-Aldrich UK Ltd (Dorset, UK).
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The Dodson paper actually conflicts with our Seckel work! This is not the same
process and we have major issues with how these experiments were conducted
(very high doses of IR and very long incubation time). We have spoken to C,
Morrison about this and have not been able to reconcile.
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Figures
Figure 1.
Schematic of the Sckl4 critical region and the PCNT gene depicting location of
identified mutations.
(a) Genetic map of chromosome 21q22.3 with the refined Sckl4 locus, defined by
overlapping homozygous chromosomal segments in two consanguineous families,
and extending over a 2.9 Mbp interval between SNP markers rs1598206 and
rs2330591 (43,883,204 – 46,751,852, UCSC Browser, March 2006 Assembly).
Genetic distances, Decode genetic map. (b) PCNT spans 122kb of genomic sequence
in 47 exons and encodes a 3336 amino acid protein. (c) Sequence electropherograms
of PCNT mutations. (d) Schematic of the pericentrin protein indicating position of
identified mutations and protein structure. Pericentrin contains internal repeats (red),
coiled-coil regions (green), and a PACT domain (blue). Protein structural regions as
predicted by SMART. Sites of interaction with PKA and calmodulin indicated by
asterisks.
Figure 2. Pericentrin localisation and function is disrupted in PCNT-Seckel cell
lines.
(a) Pericentrin is not localised to the pericentiolar material in PCNT-Seckel cells.
Deconvolved immunofluorescent images from PCNT-Seckel and control
lymphoblastoid cell lines. Pericentrin (ab448-100, green) and centrin (red). Scale bar
5m. Control, heterozygote relative, PCNT220X/+. (b) Immunoblot of LCL cell lysates
with Pericentrin ab448-100 antibody, that detects both Pericentrin A and B isoforms.
Two pericentrin (arrowheads) isoforms are absent from PCNT-Seckel cells, but
present in control lymphoblastoid cells from heterozygous relatives. A smaller protein
product of ~170kD is detected in the PCNT220X cell line, possibly produced as the
result of aberrant, re-initiated translation. Loading control, alpha-tubulin. (c,d) γ–
tubulin localisation is frequently reduced or absent during mitosis in PCNT-Seckel
cells. (c) Quantification of γ-tubulin signal in PCNT-Seckel mitotic cells, relative to 
wild-type. n=20. error bar, s.d. (d) In PCNT-Seckel mitotic cells (astericks), γ–tubulin 
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centrosomal staining is reduced (arrows) or absent, relative to centrosomal staining in
adjacent interphase cells, or in control cells from a heterozygous relative.
Figure 3
PCNT is required for ATR dependent DNA damage signalling.
(a) G2-M checkpoint arrest was observed 2 h post UV treatment in control but not in
ATR- or PCNT-Seckel LCLs. The mitotic index was examined 2 hours after
treatment with 5 J m-2 UV. Average of 3 experiments, error bars, s.d. Controls:-
heterozygote relatives PCNTE220X/+ and PCNTS629fs/+ ; and an unrelated wild type
(WT) control. UNT, untreated; UV, UV-C treated. (b) ATR- and PCNT-Seckel LCL
cells have increased hydroxyurea-induced nuclear fragmentation. Nuclear
fragmentation was examined 24 h after treatment with 5mM hydroxyurea (HU).
Percentage of cells displaying nuclear fragmentation (NF) is shown. (c) ATR- and
PCNT-Seckel LCL cells exhibit elevated levels of supernumerary centrosomes in
mitosis. Percentage of mitotic (phospho-histoneH3 (Ser10) positive cells) with > 2
centrosomes determined following 24 h incubation with nocodazole. (d) H2AX foci
formation is normal in PCNT-Seckel LCLs. Phosphorylation of the histone H2AX
(termed H2AX) by the PI3K-kinases is one of the earliest detectable responses to
DNA damage, and is ATR-signalling specific after hydroxyurea treatment.
Percentage of H2AX foci was determined 2 hours after treatment with 5mM
hydroxyurea.(e) ATR- and PCNT-Seckel cells show reduced 53BP foci formation
after treatment with 5mM hydroxyurea for 2 hrs, reflecting impairment in ATR/Chk1
dependent signalling. Immunofluorescent staining with anti-BrdU confirmed that all
LCLs had equivalent S-phase populations (range: 20-23%) prior to exposure to HU.
(f) G2-M checkpoint arrest after Ionizing Radiation (IR) is normal in PCNT-Seckel
and ATR-Seckel LCLs but not in Ataxia Telangiectasia mutated (ATM) LCLs.
Figure 4 Model of Pericentrin’s role in ATR-dependent G2/M checkpoint arrest
Low-dose UV and Hydroxyurea activate ATR kinase which then phosphorylates
downstream targets including Chk1 kinase. Activating phosphorylation is required
for accumulation of Chk1 at the centrosome after DNA damage27. Direct or indirect
binding of Chk1 by pericentrin could mediate Chk1’s localisation to the centrosome.
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Chk1 localisation at the centrosome inhibits Cdc25, preventing Cyclin B/Cdk1
activation26 and thus the transition from G2 in to mitosis.
Supplementary Figure 1
(a) Clinical details of probands from families 1-3. Growth parameters expressed in
standard deviations from the relevant age and sex-related mean. Actual
measurements in brackets. Wgt, weight; Hgt, height, OFC, occipitofrontal
circumference. Previous reported growth parameters in an unselected cohort of
Seckel patients1, were mean birth weight, 1.54kg (range, 1.0-2.06 kg), and height at
examination of –7s.d. (+/- 2.1 s.d.), and a mean OFC of –8.8 s.d (range –5.1 to –13.3
s.d.). (b) A 13 year-old individual with PCNT-Seckel, showing markedly reduced
stature and microcephaly, compared with her unaffected xx year-old sister.
Supplementary Figure 2
(a) Pedigrees of Families 1 and 2. Asterisk indicates individuals included in genome-
wide SNP genotyping and linkage analysis. (b) Total multipoint LODscores for
families 1 and 2 for chromosome 21. Distance in centiMorgans, Decode genetic map.
Critical region defined by overlapping homozygous segments in the three affected
individuals indicated by arrows (rs1598206, 64.25cM; rs2330591, 77.9cM).
Supplementary Figure 3
Pericentrin is not detectable at the centrosomes in PCNT-Seckel LCLs using the
PCNT N-20 antibody. Control, heterozygote relative, PCNT220X/+.
Supplementary Figure 4
ASPM (a), PCM1 (b), and Ninein (c) are normally localised in PCNT-Seckel LCLs.
A normal mitotic spindle and midbody is formed in PCNT-Seckel cells (a). Control,
heterozygote relative, PCNT220X/+. Scale bar 5m.
Supplementary Table 1
PCNT primer sequences.
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selling points for letter to editor
- New human disease gene, in a key gene thought essential for mitosis in
vertebrates Cell, Doxsey.
- phenotype, with evolutionary paralleles similar to Homo Floresiensis
- New component of the ATR signalling pathway, and implicating a structural
centrosomal protein in this pathway
Convergence of centrosomes and ATR signalling in the aetiology of microcephaly
